Ephrat Levy‐Lahad

18.2k total citations · 4 hit papers
163 papers, 10.0k citations indexed

About

Ephrat Levy‐Lahad is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ephrat Levy‐Lahad has authored 163 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Genetics, 76 papers in Molecular Biology and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ephrat Levy‐Lahad's work include BRCA gene mutations in cancer (38 papers), Prenatal Screening and Diagnostics (27 papers) and Genomic variations and chromosomal abnormalities (16 papers). Ephrat Levy‐Lahad is often cited by papers focused on BRCA gene mutations in cancer (38 papers), Prenatal Screening and Diagnostics (27 papers) and Genomic variations and chromosomal abnormalities (16 papers). Ephrat Levy‐Lahad collaborates with scholars based in Israel, United States and United Kingdom. Ephrat Levy‐Lahad's co-authors include Paul Renbaum, Thomas D. Bird, Amnon Lahad, Ellen M. Wijsman, Ellen Nemens, Mary‐Claire King, Eitan Friedman, Gerard D. Schellenberg, Parvoneh Poorkaj and Robert S. Wildin and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ephrat Levy‐Lahad

157 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus

1995 2.0k citations Ephrat Levy‐Lahad et al. profile →
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

2001 1.4k citations Robert S. Wildin, Ephrat Levy‐Lahad et al. profile →
A Familial Alzheimer's Disease Locus on Chromosome 1

1995 594 citations Ephrat Levy‐Lahad et al. profile →
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

2022 98 citations Cristiana Sessa, Judith Balmañà et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ephrat Levy‐Lahad Israel	44	4.0k	3.2k	3.1k	1.4k	1.1k	163	10.0k
Martin Farrall United Kingdom	47	3.1k 0.8×	3.2k 1.0×	1.7k 0.6×	1.5k 1.1×	782 0.7×	123	10.2k
Peter B. Crino United States	57	4.7k 1.2×	2.2k 0.7×	3.9k 1.3×	325 0.2×	858 0.8×	145	9.7k
Thomas Meitinger Germany	69	11.2k 2.8×	5.5k 1.7×	1.3k 0.4×	672 0.5×	532 0.5×	319	19.1k
Thierry Frébourg France	60	6.5k 1.6×	2.7k 0.8×	2.5k 0.8×	611 0.4×	384 0.3×	276	14.1k
Anders Nykjær Denmark	56	5.3k 1.3×	1.0k 0.3×	2.7k 0.9×	911 0.6×	319 0.3×	134	12.7k
Catherine Godson Ireland	58	5.1k 1.3×	809 0.3×	1.1k 0.3×	2.5k 1.7×	418 0.4×	155	11.2k
Шломо Мелмед United States	94	6.7k 1.6×	2.1k 0.7×	1.3k 0.4×	1.4k 1.0×	711 0.6×	477	31.2k
Dirk Troost Netherlands	59	4.4k 1.1×	629 0.2×	1.6k 0.5×	663 0.5×	982 0.9×	197	11.3k
Robert Feil Germany	57	6.0k 1.5×	799 0.3×	2.5k 0.8×	1.2k 0.9×	177 0.2×	160	10.6k
Hugo W. Moser United States	66	11.0k 2.7×	1.1k 0.4×	4.0k 1.3×	875 0.6×	543 0.5×	275	14.4k

Countries citing papers authored by Ephrat Levy‐Lahad

Since Specialization

Citations

This map shows the geographic impact of Ephrat Levy‐Lahad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ephrat Levy‐Lahad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ephrat Levy‐Lahad more than expected).

Fields of papers citing papers by Ephrat Levy‐Lahad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ephrat Levy‐Lahad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ephrat Levy‐Lahad. The network helps show where Ephrat Levy‐Lahad may publish in the future.

Co-authorship network of co-authors of Ephrat Levy‐Lahad

This figure shows the co-authorship network connecting the top 25 collaborators of Ephrat Levy‐Lahad. A scholar is included among the top collaborators of Ephrat Levy‐Lahad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ephrat Levy‐Lahad. Ephrat Levy‐Lahad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lieberman, Sari, Ming K. Lee, Süleyman Gülsüner, et al.. (2024). TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. JNCI Journal of the National Cancer Institute. 117(5). 1069–1073.

Michaelson‐Cohen, Rachel, Matan J. Cohen, Dan Greenberg, et al.. (2022). Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers. 14(24). 6113–6113. 4 indexed citations

Stupp, Doron, et al.. (2022). Machine-learning of complex evolutionary signals improves classification of SNVs. NAR Genomics and Bioinformatics. 4(2). lqac025–lqac025. 4 indexed citations

Sessa, Cristiana, Judith Balmañà, Sharon L. Bober, et al.. (2022). Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Annals of Oncology. 34(1). 33–47. 98 indexed citations breakdown →

Fridman, Hila, Helger G. Yntema, Reedik Mägi, et al.. (2021). The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects. The American Journal of Human Genetics. 108(4). 608–619. 34 indexed citations

Pierce, Sarah B., Christina Canavati, Amal Abu Rayyan, et al.. (2020). Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities. Molecular Case Studies. 6(5). a005652–a005652. 5 indexed citations

Fridman, Hila, Doron M. Behar, Shai Carmi, & Ephrat Levy‐Lahad. (2019). Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants. Genetics in Medicine. 22(3). 646–653. 23 indexed citations

Lieberman, Sari, et al.. (2016). Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience. Genetics in Medicine. 19(6). 628–634. 25 indexed citations

Weinberg‐Shukron, Ariella, Abdulsalam Abu‐Libdeh, Liran Carmel, et al.. (2015). Combined mineralocorticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress. Journal of Medical Genetics. 52(9). 636–641. 28 indexed citations

10.

Segel, Reeval, Mary‐Claire King, & Ephrat Levy‐Lahad. (2014). Dr. Segel and colleagues reply. Lirias (KU Leuven). 371(5). 50 indexed citations

11.

Shkedi‐Rafid, Shiri, et al.. (2012). BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening. Genetics in Medicine. 14(7). 688–694. 17 indexed citations

12.

Pierce, Sarah B., Cailyn H. Spurrell, Jessica B. Mandell, et al.. (2011). Garrod's fourth inborn error of metabolism solved by the identification of mutations causing pentosuria. Proceedings of the National Academy of Sciences. 108(45). 18313–18317. 11 indexed citations

13.

Ben‐Yosef, Dalit, Ami Amit, Mira Malcov, et al.. (2011). Female Sex Bias in Human Embryonic Stem Cell Lines. Stem Cells and Development. 21(3). 363–372. 21 indexed citations

14.

Wolf, Ingo, Yael Laitman, Tamar Rubinek, et al.. (2009). Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Oncogene. 29(1). 26–33. 40 indexed citations

15.

Altarescu, Gheona, Talia Eldar‐Geva, B. Brooks, et al.. (2009). Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Human Reproduction. 24(12). 3225–3229. 20 indexed citations

16.

Kaplan, Michael, Paul Renbaum, Hendrik J. Vreman, et al.. (2007). (TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates. Pediatric Research. 61(6). 727–731. 27 indexed citations

17.

Kaplan, Michael, Cathy Hammerman, Firmino F. Rubaltelli, et al.. (2002). Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism. Hepatology. 35(4). 905–911. 40 indexed citations

18.

Levy‐Lahad, Ephrat & Robert S. Wildin. (2001). Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome. The Journal of Pediatrics. 138(4). 577–580. 56 indexed citations

19.

Kreiss, Yitshak, et al.. (2000). The Founder Mutations in the BRCA1 , BRCA2 , and ATM Genes in Moroccan Jewish Women with Breast Cancer. Genetic Testing. 4(4). 403–407. 10 indexed citations

20.

Zevin, Shoshana, Aya Abrahamov, Irith Hadas‐Halpern, et al.. (1993). Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.. PubMed. 86(9). 565–73. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact